Hold at $80.64 — patience with discipline over directional conviction
Hold at $80.64. Both directional extremes have destroyed alpha in this exact configuration across prior decision history — 9/21 Overweight produced -0.6% alpha, 9/25 Underweight produced -1.7% capped capture, while 9/24 Hold produced +2.0% alpha. The valuation floor (5.36x forward P/E, 30% FCF yield, 9% buyback yield) prevents Underweight. The broken short-term momentum stack (MACD expanding negative, multi-MA breakdown, no reversal candle) prevents Overweight. The 200 SMA at $80.41 is the operative signal — if it holds, floor-defense thesis dominates; if it breaks on volume, trim-trigger converts to Underweight. Patience with discipline is the alpha source, not conviction in either direction. Price target $85.00.
| Position | Action |
|---|---|
| Current position | Maintain current size — position must be sized to survive 25% drawdown without forcing the stop |
| Add/upgrade trigger fires | No full-conviction adds; wait for full validation of 50 SMA reclaim with RSI>50 and MACD contraction |
| Trim/downgrade trigger fires | Execute 35-45% trim magnitude per 9/25 lesson |
| No triggers fire | No aggressive trims — simpler stop architecture outperforms elaborate tiered frameworks |
GM at $80.64 represents a generational value entry with a 5.36x forward P/E, 30% FCF yield, and 9.3% annual buyback yield, testing the rising 200 SMA in a confirmed long-term uptrend with regulatory tailwinds and a recovering EPS trajectory that makes waiting the actual risk.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 83.04 | bearish |
| 50 SMA | 85.36 | bearish |
| 200 SMA | 80.41 | neutral |
| RSI (14) | 41.23 | bearish |
| MACD | -0.94 | bearish |
| MACD Signal | -0.41 | bearish |
| MACD Histogram | -0.53 | bearish |
| Bollinger Upper Band | 88.75 | bearish |
| Bollinger Middle Band | 84.65 | bearish |
| Bollinger Lower Band | 80.55 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Weekly close < $80.00 on volume > 10M shares confirms structural break
Then: Execute 35-45% trim, opens downside to $76-78 cluster
↩ rebuts: “Bear's characterization of GM as distressed”
EV: +9.3% to 14.1% · concedes: Even at half the $15.04 forward EPS estimate, forward P/E would be ~10.7x — still cheap; Q2 2026 margin compressed to 7.6% (acknowledged as quarter-over-quarter cyclical noise); Mixed news sentiment (5.1/10) exists but is viewed as buy signal at 5x earnings; Beta 1.32 and 202% D/E are real risks that justify the valuation discount; 202% D/E ratio is a risk that requires beta-adjusted position sizing; Technical weakness (negative MACD, below 50 SMA) is real and accurate; Single-day capitulation volume of 21.1M shares (vs. typical 7-9M) was a high-volume sell-off; China competition threat is real, not imaginary
GM's 5x forward earnings multiple is appropriate and potentially generous given deteriorating fundamentals, not a "screaming value anomaly" — it is a cyclical value trap.
· concedes: 200 SMA tests can sometimes be buying opportunities in confirmed setups; Analyst consensus of $15.04 is the Street's official forward estimate; At $7.50 forward EPS, GM is peer-average (10.7x) not dramatically overvalued; GM has historically earned $9-11 EPS during recovery cycles (2023-2024); The stock has some value support at current levels relative to book and asset backing
→ vs conservative: ROE of 3.16% is cyclical bottom distortion from Q4 2025 $3.3B loss, not structural value destruction; forward earnings consensus of $15 implies massive normalization
→ vs conservative: Being at 200 SMA, not 50 SMA, is the more important level for long-term trend; long-term uptrend is intact and this is a level to add, not sit still
→ vs neutral: CFO's 'lean as possible' language is standard expectation-setting before negotiations, not a collapse forecast
→ vs neutral: Short side admitted to be 'dangerous' given buyback dynamics yet somehow long side is a tough call is inconsistent logic
→ vs conservative: Waiting for reversal candle means buying 30-50 cents higher with worse risk-reward; price action at support precedes the candle
| 2.60 |
| neutral |
Support: 80.55 · 80.41 · 78 | Resistance: 83.04 · 84.65 · 85.36 · 88.75
GM closed at $80.64 on 2026-09-28, sitting just above the critical lower Bollinger Band ($80.55) and 200-day SMA ($80.41) support zone. The stock is in a clear short-term downtrend, trading below the 50 SMA ($85.36), 10 EMA ($83.04), and Bollinger middle band ($84.65). Bearish alignment stacks: 50 SMA ($85.36) > 10 EMA ($83.04) > Price ($80.64) > 200 SMA ($80.41). Momentum is negative with MACD at -0.94 (expanding histogram -0.53) and RSI at 41.23 (not oversold). ATR is elevated at $2.60, up 18% in two weeks. A high-volume breakdown on 2026-09-18 (21.1M shares vs. typical 7–9M) broke below the 50 SMA. Overall rating: HOLD for existing positions with tight stops; avoid initiating new longs until the 50 SMA is reclaimed or a clean reversal forms off the $80.40–$80.55 support zone. A close below $80.00 would invalidate the long-term uptrend thesis.
Market Cap
$72.93 B
P/E (TTM)
36.0x
Forward P/E
5.36x
PEG Ratio
0.29
P/B
1.14x
EPS (TTM)
$2.24
Forward EPS
$15.04
Current Price (implied)
~$83.10
52-Week High
$91.85
52-Week Low
$54.33
50-Day MA
$85.39
200-Day MA
$80.71
Beta
1.32
Dividend Yield
0.87%
Revenue (TTM)
$185.53 B
Gross Profit (TTM)
$18.88 B
EBITDA (TTM)
$16.46 B
Net Income (TTM)
$1.86 B
Operating Margin (TTM)
3.20%
Net Margin (TTM)
1.05%
ROE
3.16%
ROA
2.25%
Total Assets (Q2 2026)
$282.7 B
Cash & Equivalents (Q2 2026)
$24.7 B
Total Debt (Q2 2026)
$127.7 B
Net Debt (Q2 2026)
$107.6 B
Stockholders Equity (Q2 2026)
$62.0 B
Shares Outstanding (Q2 2026)
877.5 M
D/E Ratio
2.06x
Free Cash Flow (TTM)
$21.93 B
Operating CF (Q2 2026)
$6.35 B
CapEx (Q2 2026)
-$1.94 B
Buybacks (Q2 2026)
-$2.00 B
Buyback Yield (Annualized)
~9.3%
Combined Shareholder Yield
~10–13%
Q2 2026 Diluted EPS
$1.41
Q1 2026 Diluted EPS
$2.82
Q4 2025 Diluted EPS
-$3.50
Q3 2025 Diluted EPS
$1.35
Q2 2025 Diluted EPS
$1.91
Q1 2025 Diluted EPS
$3.35
Q2 2026 Revenue
$48.03 B
Q2 2026 Gross Profit
$3.66 B
Q2 2026 Operating Income
$1.46 B
Q2 2026 Net Income
$1.31 B
Net Debt / EBITDA
~6.5x
FCF / Market Cap
~30%
Strengths
Concerns
GM represents a high-conviction cyclical value opportunity with compelling forward valuation (5.36x P/E, 0.29 PEG) against a backdrop of exceptional shareholder returns (~10-13% combined yield), active deleveraging, and shrinking share count, though the investment case hinges on whether Q3 2026 confirms margin recovery from the Q4 2025 loss trough given thin profitability metrics and elevated leverage.
Macro: Treasury yields continue climbing with Moody's Zandi warning higher rates are 'already damaging the economy'; 'higher-for-longer Fed' narrative reinforced by 97% implied probability of no cuts in 2026 ($8.6M Polymarket volume); broad market pressured by yield-driven equity selloff; consumer cyclical sector mixed with bifurcated Detroit narrative (regulatory relief vs. competitive intensification); China 2026 GDP 92% implied between 4.0-5.0% confirming slow grind backdrop pushing OEMs toward US as safe haven.